Main Topic Area
All Topic Areas
1 - 10 of 1135 more >>
Articles
1 - 5 of 13 more >>
- Oral Contraceptives and Cancer Risk
Key Points There is evidence of an increased risk of breast cancer for women under age 35 who are recent users of OCs (see section on Breast Cancer). Studies have consistently shown that using OCs reduces the risk of ovarian cancer (see section on Ovarian and Endometrial Cancers). There is evidence that long-term use of OCs may increase the risk of cancer of the cervix (see section on Cancer of the Cervix). There is some evidence that OCs may increase the risk of certain cancerous liver tumors...
- Lip and Oral Cavity Cancer Treatment
Treatment depends on where the cancer is in the lip or mouth. Treatment depends on where the cancer is in the lip or mouth. In addition to the treatments listed below, a patient will probably have radiation therapy to the neck with or without surgery to remove lymph nodes in the neck (lymph node dissection). Treatment depends on the type of treatment the patient had before. If radiation therapy was given, the patient may have surgery when the cancer comes back. If surgery was used, the patient...
National Cancer Institute
- Oral Complications of Chemotherapy and Radiation
This patient summary on oral complications of cancer and cancer therapy is adapted from the summary written for health professionals by cancer experts. This and other accurate, credible information about cancer treatment, screening, prevention, supportive care, and ongoing clinical trials is available from the National Cancer Institute. Oral complications are common in cancer patients, especially those with head and neck cancer. This summary describes oral complications caused by chemotherapy...
National Cancer Institute
- Oral Insulin Does Not Prevent Type 1 Diabetes
Insulin taken orally does not delay or prevent type 1 diabetes in people at moderate risk (25 to 50 percent likelihood) of developing type 1 diabetes in 5 years, researchers reported today at the annual meeting of the American Diabetes Association. The finding emerged from the second trial conducted as part of the Diabetes Prevention Trial-Type 1 (DPT-1), which ended last month. The other DPT-1 trial, completed two years ago, found that low-dose insulin injections failed to prevent or delay...
National Institutes of Health
- Interstitial Cystitis Study Finds Limited Benefit in Two Oral Drugs
An 18-month pilot study of two commonly available treatments has shown no significant benefit in patients with interstitial cystitis (IC). The results are reported in the September issue of the Journal of Urology. The first in a series of treatment studies planned by the IC Clinical Trials Group tested the effectiveness of pentosan polysulfate sodium (Elmiron®) and hydroxyzine hydrochloride (Atarax®) in 121 patients with IC. Most volunteers reported experiencing moderate pain, discomfort, and...
National Institutes of Health
Organizations
1 - 5 of 7 more >>
- Oral Cancer Foundation -
- American Association of Oral and Maxillofacial Surgeons -
- National Oral Health Information Clearinghouse -
- Support for People with Oral and Head and Neck Cancer, Inc. - http://www.spohnc.org/
- Division of Oral Health, NCCDPHP, CDC, OPHS, HHS - http://www.cdc.gov/nccdphp/oh/index.htm
News
1 - 5 of 951 more >>
- Bausch & Lomb recalls second contact lens solution
Reuters - Tue, 06 Mar 2007 05:15 EST
- Bausch & Lomb recalls second contact lens solution
Reuters - Tue, 06 Mar 2007 03:42 EST
- Bausch & Lomb recalls more lens solution
MSNBC - Tue, 06 Mar 2007 02:28 EST
- Actavis Receives Approval For Ranitidine Syrup In The U.S.
MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
- Wyeth And Progenics To Begin Clinical Testing Of A New Formulation Of Oral Methylnaltrexone Based On Phase 2 Findings
MedicalNewsToday - Wed, 07 Mar 2007 08:00 EST
Clinical Trials
1 - 5 of 1125 more >>
- Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.
ClinicalTrials.gov Identifier: NCT00204165 - Active, not recruiting
Magnetic Resonance Imaging, Intestine Small, Crohn Disease.
- Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
Transplantation; Kidney Transplantation; Immunosuppression
- Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
- Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
ClinicalTrials.gov Identifier: NCT00319605 - Recruiting
Epilepsy
- Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
ClinicalTrials.gov Identifier: NCT00086281 - Active, not recruiting
Obstructive Sleep Apnea Syndrome

Not Signed In -

